本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Replimune Group Inc.

7.11
+0.10001.43%
成交量:22.33萬
成交額:155.69萬
市值:5.48億
市盈率:-2.40
高:7.11
開:7.08
低:6.84
收:7.01
資料載入中...

公司資料

公司名字:
Replimune Group Inc.
交易所:
NASDAQ
成立時間:
2015
員工人數:
331
公司地址:
500 Unicorn Park Drive,Suite 303,Woburn,Massachusetts,United States
郵編:
01801
電話:
傳真:
- -
簡介:
Replimune Group, Inc.於2015年在特拉華州註冊成立。該公司是一家臨床階段的生物技術公司,致力於應用他們在溶瘤免疫治療領域的領先專業技術,改變癌症患者的生活。使用該公司專有的Immulytic平台來設計和開發旨在最大限度激活免疫系統對抗癌症的候選產品。

董事

名稱
職位
Philip Astley Sparke
Chief Executive Officer and Director
Robert Coffin
President, Chief Research and Development Officer and Director
Christy Oliger
Director
Dieter Weinand
Director
Hyam Levitsky
Director
Joseph Slattery
Director
Kapil Dhingra
Director
Paolo Pucci
Director
Veleka Peeples Dyer
Director

股東

名稱
職位
Philip Astley Sparke
Chief Executive Officer and Director
Colin Love
Chief Operating Officer
Andrew Schwendenman
Chief Accounting Officer and Treasurer
Christopher Sarchi
Chief Commercial Officer
Konstantinos Xynos
Chief Medical Officer
Pamela Esposito
Chief Business Officer
Robert Coffin
President, Chief Research and Development Officer and Director
Sushil Patel
Chief Strategy Officer
Tanya Lewis
Chief Development Operations Officer